HCRT and papilloma: Previous studies indicate that in vivo electroporation greatly enhances DNA delivery (44, –, 46), and therefore, the 4 SKH-1 mice with persistent papillomas were vaccinated three times biweekly with hCRT-mE6mE7mL2 DNA by in vivo electroporation.